Search Results 151-160 of 20602 for Ulcerative+colitis
Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to ulcerative colitis or Crohn's disease focuses on reducing inflammation in the ...
A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.
This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis (UC) who have not responded at the end ...
To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...
... IBD, and irritable bowel syndrome, or IBS ... Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease.
Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis · Overview · Participation eligibility.
Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...
... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.
Description. Etrasimod is used to treat moderate to severe active ulcerative colitis. This medicine is available only with your doctor's prescription. This ...
A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.